{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:43:21Z","timestamp":1784673801499,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","award":["GHP\/326\/22GD"],"award-info":[{"award-number":["GHP\/326\/22GD"]}],"id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Hong Kong Food and Health Bureau","doi-asserted-by":"publisher","award":["08192316"],"award-info":[{"award-number":["08192316"]}],"id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program Key Projects","doi-asserted-by":"publisher","award":["SGDX20210823103537031"],"award-info":[{"award-number":["SGDX20210823103537031"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA0806102"],"award-info":[{"award-number":["2022YFA0806102"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","award":["AoE\/M\/707\\u201318"],"award-info":[{"award-number":["AoE\/M\/707\\u201318"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jare.2025.09.033","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:38:21Z","timestamp":1758620301000},"page":"871-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and clinical validation of a novel protein biomarkers-based algorithm for risk prediction and diagnosis of advanced liver fibrosis: a multi-centre study"],"prefix":"10.1016","volume":"84","author":[{"given":"Chloe Yu-Yan","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Ho-Yi","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Tak-Wai","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Sun","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9559-3467","authenticated-orcid":false,"given":"Yu-Cho","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-0416","authenticated-orcid":false,"given":"Kathryn Choon-Beng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Kay","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunchuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Siu-Ling","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jare.2025.09.033_b0005","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jare.2025.09.033_b0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jare.2025.09.033_b0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Wymer M Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jare.2025.09.033_b0020","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.jare.2025.09.033_b0025","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective Study of Outcomes in adults with Nonalcoholic Fatty Liver Disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jare.2025.09.033_b0030","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jare.2025.09.033_b0035","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jare.2025.09.033_b0040","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jare.2025.09.033_b0045","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"},{"issue":"10319","key":"10.1016\/j.jare.2025.09.033_b0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jare.2025.09.033_b0055","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jare.2025.09.033_b0060","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/jgh.15482","article-title":"Rosenberg W Systematic review: Accuracy of the enhanced liver fibrosis test for diagnosing advanced liver fibrosis and cirrhosis","volume":"36","author":"Sharma","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jare.2025.09.033_b0065","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/apt.17385","article-title":"Meta-analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases","volume":"57","author":"Hinkson","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jare.2025.09.033_b0070","article-title":"Guideline Development G Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance","volume":"354","author":"Glen","year":"2016","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.jare.2025.09.033_b0075","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jare.2025.09.033_b0080","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2020.03.036","article-title":"Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis","volume":"73","author":"Vali","year":"2020","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jare.2025.09.033_b0085","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/hep.31995","article-title":"Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis","volume":"74","author":"Kozumi","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jare.2025.09.033_b0090","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/liv.14776","article-title":"Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD","volume":"41","author":"Kimura","year":"2021","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.jare.2025.09.033_b0095","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2337\/dc21-0131","article-title":"Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes","volume":"44","author":"Lee","year":"2021","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jare.2025.09.033_b0100","doi-asserted-by":"crossref","first-page":"e3230","DOI":"10.1210\/clinem\/dgac292","article-title":"Serum Thrombospondin-2 Levels are closely Associated with the Severity of Metabolic Syndrome and Metabolic Associated Fatty Liver Disease","volume":"107","author":"Wu","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jare.2025.09.033_b0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009712","article-title":"Lawler J the thrombospondins","volume":"3","author":"Adams","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10","key":"10.1016\/j.jare.2025.09.033_b0110","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/db18-1001","article-title":"Elevated Thrombospondin 2 Contributes to delayed Wound Healing in Diabetes","volume":"68","author":"Kunkemoeller","year":"2019","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jare.2025.09.033_b0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jare.2025.09.033_b0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/j.gastro.2015.05.039","article-title":"High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery","volume":"149","author":"Xanthakos","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jare.2025.09.033_b0125","doi-asserted-by":"crossref","first-page":"G744","DOI":"10.1152\/ajpgi.00339.2018","article-title":"You H Multitranscriptome analyses reveal prioritized genes specifically associated with liver fibrosis progression independent of etiology","volume":"316","author":"Chen","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"10.1016\/j.jare.2025.09.033_b0130","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1210\/clinem\/dgad186","article-title":"Central Sensitivity to Free Triiodothyronine with MAFLD and its Progression to Liver Fibrosis in Euthyroid adults","volume":"108","author":"Wan","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jare.2025.09.033_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2024.102973","article-title":"Prevalence and risk factors of MAFLD and its metabolic comorbidities in community-based adults in China: a cross-sectional study","volume":"18","author":"He","year":"2024","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jare.2025.09.033_b0140","article-title":"LiverHome study group. High prevalence of steatotic liver disease and fibrosis in the general population: a large prospective study in China","author":"Liu","year":"2024","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jare.2025.09.033_b0145","article-title":"Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese chinese","volume":"4","author":"Jia","year":"2023","journal-title":"Cell Rep Med"},{"issue":"5","key":"10.1016\/j.jare.2025.09.033_b0150","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jare.2025.09.033_b0155","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study","volume":"65","author":"Kwok","year":"2016","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jare.2025.09.033_b0160","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jare.2025.09.033_b0165","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Network NCR Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jare.2025.09.033_b0170","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Consortium FP Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, activity, and Fibrosis (SAF) score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jare.2025.09.033_b0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/HEP.0000000000000542","article-title":"Serum identification of at-risk MASH: the metabolomics-advanced steatohepatitis fibrosis score (MASEF)","volume":"79","author":"Noureddin","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jare.2025.09.033_b0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.gastro.2008.09.013","article-title":"Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease","volume":"136","author":"Nobili","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jare.2025.09.033_b0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2893.2009.01263.x","article-title":"Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C","volume":"18","author":"Parkes","year":"2011","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.jare.2025.09.033_b0190","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Clarke-Pearson DL Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.jare.2025.09.033_b0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2015.37","article-title":"Lewis RJ Decision curve analysis","volume":"313","author":"Fitzgerald","year":"2015","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.jare.2025.09.033_b0200","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"European Association for the Study of Diabetes, European Association for the Study of Obesity EASL-EASD-EASO Clinical Practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the Liver","year":"2024","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jare.2025.09.033_b0205","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.bbagen.2014.01.013","article-title":"Kyriakides TR Thrombospondin-2 and extracellular matrix assembly","volume":"1840","author":"Calabro","year":"2014","journal-title":"BBA-Gen Subjects"},{"issue":"9","key":"10.1016\/j.jare.2025.09.033_b0210","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/002215549804600904","article-title":"Bornstein P The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice","volume":"46","author":"Kyriakides","year":"1998","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jare.2025.09.033_b0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.matbio.2019.03.002","article-title":"Thrombospondin-2 regulates extracellular matrix production, LOX levels, and cross-linking via downregulation of miR-29","volume":"82","author":"Calabro","year":"2019","journal-title":"Matrix Biol"},{"issue":"5","key":"10.1016\/j.jare.2025.09.033_b0220","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep4.1670","article-title":"SOMAscan Proteomics Identifies Serum Biomarkers Associated with Liver Fibrosis in patients with NASH","volume":"5","author":"Luo","year":"2021","journal-title":"Hepatology Communications"},{"issue":"48","key":"10.1016\/j.jare.2025.09.033_b0225","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Wang CX Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jare.2025.09.033_b0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2021.03.022","article-title":"Cao D Distribution of serum Thrombospondin-2, a novel tumor marker, in general population and cancer patients in China","volume":"518","author":"Zou","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.jare.2025.09.033_b0235","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jmri.24529","article-title":"Comparison between T1 Relaxation Time of Gd-EOB-DTPA-Enhanced MRI and Liver Stiffness Measurement of Ultrasound Elastography in the Evaluation of Cirrhotic Liver","volume":"41","author":"Okada","year":"2015","journal-title":"J Magn Reson Imaging"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225007374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225007374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:48:48Z","timestamp":1780516128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225007374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S2090123225007374"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.09.033","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and clinical validation of a novel protein biomarkers-based algorithm for risk prediction and diagnosis of advanced liver fibrosis: a multi-centre study","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}